Clin. Exp. Immunol. 1999 — Article demonstrates that beta glucan’s CR3 binding properties can be effective against cancer tumor cells that do not have CR3 receptor sites by potentiating natural killer (NK) cells to see the tumor cells as non-self. Read more…
Regulation of CR3 (CD11b/CD18) Dependent Natural Killer (NK) Cell Cytotoxicity by Tumour Target Cell MHC class I Molecules
by jowen | Sep 28, 2018 | Cancer, Immunity/Immune Response/Immune Response | 0 comments